New HIV pill dose for kids shows promise in african study
Disease control
Completed
This study tested a new combination of three HIV drugs (dolutegravir, emtricitabine, and tenofovir alafenamide) in 53 children aged 28 days to 10 years in Africa. The goal was to find a dose that gives enough medicine in the blood and is safe. If it works, this could lead to a si…
Phase: PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC